Skip to main content

Table 2 Mean dose of severe deterioration group versus mild deterioration group

From: Dosimetric factors associated with long-term patient-reported outcomes after definitive radiotherapy of patients with head and neck cancer

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us